A $4.6 million settlement resolves allegations that the Obesity Research Institute deceived consumers about the effectiveness of its Lipozene weight loss pills.
Class Members include those who purchased Lipozene weight loss pills between Aug. 10, 2012 and Oct. 28, 2019 for personal use.
Lead plaintiffs accused the Obesity Research Institute and Continuity Products of falsely advertising Lipozene as a “weight-loss breakthrough” that would “get rid of pounds of body fat.”
The Lipozene class action contended that, contrary to Lipozene’s advertising claims, the supplement is neither a safe nor effective treatment for weight loss.
The product’s main ingredient, glucomannan, is allegedly not absorbed by the human body. According to the Lipozene class action lawsuit, the product is basically a fiber pill that has no value for its intended purpose.
The Lipozene class action further claimed that Obesity Research Institute and Continuity Products, are simply interlinked shell companies run by the other defendants, Henny den Uijl, and Sandra den Uijl, who have a track record of selling other “worthless supplements.”
The defendants do not admit any wrongdoing but agreed to pay up to $4.6 million to end the Lipozene weight loss class action lawsuit.
Under the settlement, Class Members can make a claim for cash for the Lipozene they purchased. In addition, the defendants have agreed to change their marketing statements about Lipozene.
Class Members with proof of purchase can get $15 per bottle, up to four units. Proof of purchase may include a credit card statement or receipts.
Those without proof of purchase can claim $7 for one unit.
To benefit from this settlement Class Members must submit a Claim Form online or by mail no later than Feb. 17, 2020.
Class Members who wish to opt out of or object to the Lipozene weight loss pills class action settlement must do so by Jan. 24, 2020.
Class Members include “resident[s] of the United States who purchased Lipozene weight loss pills from August 10, 2012 through October 28, 2019.”
Up to $60.
Class Members with proof of purchase can submit a claim for $15 per bottle, up to four units. Those who are unable to provide proof can file a claim for $7 for one unit.
Proof of Purchase
Not required but Class Members with proof will receive $15 per bottle.
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
Duran v. Obesity Research Institute LLC, et al., Case No. 37-2013-00048664-CU-BT-CTL, in the Superior Court for the State of California, San Diego County
c/o Heffler Claims Group
PO Box 59269
Philadelphia, PA 19102-9269
L. Timothy Fisher
BURSOR & FISHER PA
Daniel S. Silverman
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
©2008 – 2020 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.